Deep-pocketed investors have adopted a bearish approach towards Johnson & Johnson JNJ, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JNJ usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Johnson & Johnson. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 55% bearish. Among these notable options, 2 are puts, totaling $63,388, and 7 are calls, amounting to $254,697.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $130.0 to $150.0 for Johnson & Johnson over the recent three months.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale trades within a strike price range from $130.0 to $150.0 in the last 30 days.
Johnson & Johnson Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | TRADE | BEARISH | 01/15/27 | $26.05 | $25.0 | $25.4 | $130.00 | $50.8K | 31 | 54 |
| JNJ | CALL | TRADE | BEARISH | 01/15/27 | $25.65 | $25.25 | $25.3 | $130.00 | $50.6K | 31 | 94 |
| JNJ | CALL | TRADE | BULLISH | 09/19/25 | $13.4 | $13.0 | $13.26 | $140.00 | $39.7K | 53 | 30 |
| JNJ | PUT | SWEEP | BEARISH | 01/16/26 | $8.15 | $8.0 | $8.15 | $140.00 | $31.7K | 1.7K | 39 |
| JNJ | PUT | TRADE | BEARISH | 01/15/27 | $15.8 | $15.15 | $15.8 | $150.00 | $31.6K | 116 | 20 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
After a thorough review of the options trading surrounding Johnson & Johnson, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Johnson & Johnson
- With a volume of 1,969,865, the price of JNJ is down -0.2% at $144.33.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 20 days.
Expert Opinions on Johnson & Johnson
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $170.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from B of A Securities has revised its rating downward to Neutral, adjusting the price target to $166. * Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Johnson & Johnson, targeting a price of $175.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson & Johnson with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
